J.D. Vance’s Appalachian Graveyard
By Elizabeth Catte,
In These Times
| 07. 25. 2024
"JD Vance" by Gage Skidmore licensed under CC by SA 2.0
In May, two months before his selection as Donald Trump’s running mate for the Republican ticket, Ohio Sen. J.D. Vance described his political awakening to Ross Douthat of the New York Times. It was 2018, and Vance was closing in on the two-year mark of his tenure as America’s hillbilly whisperer. His 2016 memoir, Hillbilly Elegy, had transcended its genre to become an urgent sociological text held up across the political aisle, but especially by liberals — Hillary Clinton was a fan — for its ability to humanize the tensions of a fractured political moment.
Hillbilly Elegy told the story of a young man from a marginalized region who overcame the odds to become a Yale graduate and Silicon Valley venture capitalist. It also pantomimed analysis enough that readers could nod along as Vance described his neighbors in Ohio and Kentucky as social detritus doomed by their own personal failings and struggles with addiction and poverty.
Vance’s rise to fame came courtesy of the bipartisan myth that a self-directed person unshy of hard work could overcome the structural and traumatizing...
Related Articles
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...